ABOUT THE JOURNAL

CANNABINOIDS is a peer-reviewed online journal of the International Association for Cannabis as Medicine. It is published on the website of the IACM in several languages.
All articles and letters to the editor have to be written in English.
CANNABINOIDS intends to become an important source of information on medical and scientific aspects of cannabis and the cannabinoids in the web and to inform the readers up to date on issues under discussion.
The publication of an earlier Journal of the IACM, the Journal of Cannabis Therapeutics, ceased in 2004.

Content

CANNABINOIDS consists of the following categories.
  • Mini-reviews: they give a short and up-to-date overview of important recent medical or scientific findings, ideas or issues.
  • Comments: they refer to an article recently published in another journal. They summarize the main findings and conclusions, give background information and highlight strengths and/or weaknesses of the text.
  • Letters: they are chosen from the letters sent to the editor in response to journal articles. Readers are encouraged to write letters, but publication is not guaranteed.
    Papers that do not fall into one of these categories (such as book reviews and original articles) are not excluded a priori, but are not the major focus.

    Advantages for authors

    CANNABINOIDS offers the following advantages to authors.
  • Publication of articles are announced in six languages in the IACM-Bulletin (about 5,000 subscribers).
  • Translation of an article into several languages, so that readers who do not read English well will also be reached.
  • The articles are citeable.
  • Easy access to the journal for readers, which means many potential readers.

    Format of the journal

    CANNABINOIDS has no regular rhythm of publication. This allows the publication of comments very timely, since there is no necessity to wait until the publication of the next issue. To allow citation of the articles, articles that have been published within three months will be combined to one issue. One issue has continued page numbers. Articles are written in a way that is understandable by practitioners without a specific scientific background.

    Citation

    If possible the English version should be used to cite the journal, because this is the original version that has been submitted and where necessary revised by the authors, and reviewers of the article have made their comments and suggestions on this version.

    Editor

    CANNABINOIDS is edited by Franjo Grotenhermen.
    Dr. Franjo Grotenhermen
    International Association for Cannabis as Medicine
    Rueckertstrasse 4
    D-53819 Neunkirchen
    Germany
    Phone: +49-2247-968083
    Fax: +49-2247-9159223
    E-mail: journal@cannabis-med.org

    Editorial and Advisory Board

    Donald Abrams, San Fransisco, USA
    David Baker, London, UK
    Rudolf Brenneisen, Bern, Switzerland
    Greg Chesher, Paddington, Australia
    Vincenzo Di Marzo, Naples, Italy
    Marta Duran, Barcelona, Spain
    Javier Fernandez-Ruiz, Madrid, Spain
    Ester Fride, Ariel, Israel
    Lester Grinspoon, Boston, USA
    Manuel Guzman, Madrid, Spain
    Leslie Iversen, Oxford, UK
    Markus Leweke, Cologne, Germany
    Beat Lutz, Mainz, Germany
    John McPartland, Middlebury, USA
    Raphael Mechoulam, Jerusalem, Israel
    Robert Melamede, Colorado, USA
    Kirsten Mueller-Vahl, Hannover, Germany
    Richard E. Musty, Burlington, USA
    William Notcutt, Great Yarmouth, UK
    Emmanuel Onaivi, Paterson, USA
    Daniela Parolaro, Varese, Italy
    David W. Pate, Amsterdam, The Netherlands
    Roger Pertwee, Aberdeen, UK
    Daniele Piomelli, Irvine, USA
    Philip Robson, Oxford, UK
    Ruth Ross, Aberdeen, UK
    Ethan Russo, Missoula, USA
    Rob Verpoorte, Leiden, The Netherlands
    Mark Ware, Montreal, Canada
    John Zajicek, Plymouth, UK
    Antonio Waldo Zuardi, Sao Paulo, Brasil

    up